A50 — Thomson Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual income statement for Thomson Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	R2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	334	356	351	395	420
Cost of Revenue
Gross Profit	278	296	275	295	310
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	242	274	278	379	394
Operating Profit	91.8	82.3	73.5	15.9	26.3
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	69.3	55.2	29.2	-40.6	-21.1
Provision for Income Taxes
Net Income After Taxes	58.6	41.1	18.2	-47	-27.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	53.8	36.6	14.2	-47.6	-29.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	53.8	36.6	14.2	-47.6	-29.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.002	0.001	-0	-0.001	-0.001
Dividends per Share